# US 2013/0158247 A1 · Method for isolating and/or purifying nucleic acid(s)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158247 A1
- Document ID: US20130158247A1
- Status: Published application
- Kind: A1
- Application number: 13/701,436
- Filed: 2011-06-01
- Published: 2013-06-20
- Earliest claimed: 2010-06-01
- Assignees: Qiagen GmbH
- Inventors: Roland Fabis; Jan Petzel
- Web page: https://patentgrep.com/patent/US20130158247A1

## CPC

- C12N 15/1013: {by using magnetic beads}
- C12N 15/101: {by chromatography, e.g. electrophoresis, ion-exchange, reverse phase}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a method for isolating and/or purifying one or more nucleic acid(s) from a sample, comprising the steps of essentially separating the nucleic acid(s) from the sample by binding the nucleic acid(s) to a solid phase by means of a non-chaotropic water-soluble binding ligand at a first pH (pH I), and essentially eluting the nucleic acid(s) from the solid phase at a second pH (pH II). The invention further relates to a kit for isolating and/or purifying nucleic acid(s) from a sample and/or for protecting nucleic acid(s).

## Claims

### Claim at position 1

-15. (canceled)

### Claim 16

A method for isolating and/or purifying one or more nucleic acid(s) from a sample, comprising:
(1) separating the nucleic acid(s) from the sample by binding the nucleic acid(s) to a solid phase by means of a binding ligand at a first pH (pH I), and
(2) eluting the nucleic acid(s) from the solid phase at a second pH (pH II),
wherein the binding ligand is a non-chaotropic water-soluble cationic compound comprising at least one basic moiety and/or at least one quaternary ammonium moiety, said binding ligand forms a complex with the nucleic acid(s) at a pH below or equal to pH I and wherein the solid phase and the binding ligand are brought into contact upon or after contacting the nucleic acid(s) with the binding ligand, but not before.

### Claim 17 (depends on 16)

The method according to claim 16, wherein said first pH is lower than said second pH (pH I<pH II), and wherein
said second pH is lower than the logarithmic acidity constant pKa of the conjugated acid of said basic moiety of the binding ligand (pH II<pKa) if the binding ligand comprises one or more basic moieties, or
said second pH is above seven (pH 7<pH II) if the binding ligand comprises quaternary ammonium groups.

### Claim 18 (depends on 16)

The method according to claim 16, wherein the logarithmic acidity constant pKa ranges from 9 to 12.

### Claim 19 (depends on 16)

The method according to claim 16, wherein the logarithmic acidity constant pKa ranges from 10 to 12.

### Claim 20 (depends on 16)

The method according to claim 16, wherein the binding ligand comprises more than one basic moiety per molecule.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the more than one basic moiety represents primary, secondary, and/or tertiary amino groups.

### Claim 22 (depends on 16)

The method according to claim 16, wherein the binding ligand comprises more than two basic moieties per molecule.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the more than two basic moieties represent primary, secondary, and/or tertiary amino groups.

### Claim 24 (depends on 16)

The method according to claim 16, wherein the binding ligand comprises more than three basic moieties per molecule.

### Claim 25 (depends on 24)

The method according to claim 24, wherein the more than three basic moieties represent primary, secondary, and/or tertiary amino groups.

### Claim 26 (depends on 16)

The method according to claim 16, wherein the binding ligand is a primary, secondary or tertiary mono- or polyamine.

### Claim 27 (depends on 26)

The method according to claim 26, wherein the binding ligand is selected from the group consisting of linear and branched alkylamines, cyclic amines, aromatic amines, and heteroaromatic amines.

### Claim 28 (depends on 26)

The method according to claim 26, wherein the binding ligand is selected from the group consisting of polyamines of the general structure R1R2N[(CH2)x1-x7NR3]yR4, wherein R1, R2, and R3, and R4 independently are selected from the group consisting of hydrogen, and linear or branched C1-C18 alkyl groups, x1-x7 independently represent an integer from 2 to 8, and y ranges from 1 to 7.

### Claim 29 (depends on 26)

The method according to claim 26, wherein the binding ligand is selected from the group consisting of pentaethylene hexamine, spermidine or spermine, polylysines, polyarginines, protamines, linear and branched polyethylene imines, polyallylamine hydrochlorides, polyvinylamine hydrochlorides, polydiallylmethylamine hydrochlorides, poly(diallyldimethylammoniumchlorides) (PolyDADMAC), and poly(dimethylamine-co-epichlorohydrine-co-ethylenediamines).

### Claim 30 (depends on 16)

The method according to claim 16, wherein the solid phase comprises a carrier material.

### Claim 31 (depends on 30)

The method according to claim 30, wherein the carrier material is selected from the group consisting of organic polymers, polysaccharides, and inorganic carriers.

### Claim 32 (depends on 30)

The method according to claim 30, wherein the carrier material is selected from the group consisting of polystyrenes, polyacrylates, polymethacrylates, polyurethanes, nylon, polyethylene, polypropylene, polybutylidene, and their copolymers, agarose, cellulose, dextrane, sephadex, sephacryl, chitosan, silica, quartz, glass, metal oxides, and metal surfaces.

### Claim 33 (depends on 16)

The method according to claim 16, wherein the solid phase is in the form of particle(s), bead(s), a surface coating, a tube, a paper, a multiwell plate, a chip, a micro array, a tip, a dipstick, a rod, a filter plug or pad, a resin, a mesh, and/or a membrane.

### Claim 34 (depends on 33)

The method according to claim 33, wherein the particle(s) are magnetic particles, the bead(s) are magnetic beads, and/or the resin is a resin for column and spin chromatography.

### Claim 35 (depends on 16)

The method according to claim 16, wherein the solid phase comprises acidic moieties on at least a part of that surfaces which come into contact with the sample and/or the binding ligand.

### Claim 36 (depends on 35)

The method according to claim 35, wherein the acidic moieties are selected from the group consisting of carboxylic (—CO2H), sulphonic (—SO3H), phosphinic (—PO2H), phosphonic (—PO3H) groups, and acidic hydroxyl groups (—OH).

### Claim 37 (depends on 36)

The method according to claim 36, wherein the acidic hydroxyl groups are hydroxyl groups present at silica surfaces (silanol groups) or metal oxide species.

### Claim 38 (depends on 37)

The method according to claim 37, wherein the metal oxide species are natural occurring minerals.

### Claim 39 (depends on 38)

The method according to claim 38, wherein the natural occurring minerals are hydroxyapatite.

### Claim 40 (depends on 37)

The method according to claim 37, wherein the metal oxide species comprises surface-exposed hydroxyl groups M—OH.

### Claim 41 (depends on 40)

The method according to claim 40, wherein M represents aluminum, calcium, titanium, zirconium, iron, or mixtures thereof.

### Claim 42 (depends on 16)

The method according to claim 16, wherein the ratio of binding ligand to nucleic acid is equal to or above 0.5:1.

### Claim 43 (depends on 42)

The method according to claim 42, wherein the ratio of binding ligand to nucleic acid is in the range of from 0.5:1 to 10:1 (w/w).

### Claim 44 (depends on 42)

The method according to claim 42, wherein the ratio of binding ligand to nucleic acid is in the range of from 0.5:1 to 2:1 (w/w).

### Claim 45 (depends on 42)

The method according to claim 42, wherein the ratio of binding ligand to nucleic acid is 1:1 (w/w).

### Claim 46 (depends on 16)

The method according to claim 16, wherein the step of binding the nucleic acid to the solid phase according to step (1) is carried out at a pH of from 1 to 8.

### Claim 47 (depends on 46)

The method according to claim 46, wherein the step of binding the nucleic acid to the solid phase according to step (1) is carried out at a pH of from 2 to 7.

### Claim 48 (depends on 46)

The method according to claim 46, wherein the step of binding the nucleic acid to the solid phase according to step (1) is carried out at a pH of from 3 to 6.

### Claim 49 (depends on 46)

The method according to claim 46, wherein the step of binding the nucleic acid to the solid phase according to step (1) is carried out at a pH of from 5 to 6.

### Claim 50 (depends on 16)

The method according to claim 16, wherein the step of eluting the nucleic acids from the solid phase according to step (2) is carried at a pH in the range of from 7.5 to 11.

### Claim 51 (depends on 50)

The method according to claim 50, wherein the step of eluting the nucleic acids from the solid phase according to step (2) is carried at a pH in the range of from 7.5 to 10.

### Claim 52 (depends on 51)

The method according to claim 51, wherein the step of eluting the nucleic acids from the solid phase according to step (2) is carried at a pH in the range of from 7.5 to 9.

### Claim 53 (depends on 16)

The method according to claim 16, wherein the solid phase is washed at least once using an aqueous washing liquid/washing buffer comprising a salt concentration of less than 0.5 M after binding the nucleic acid to the solid phase.

### Claim 54 (depends on 53)

The method according to claim 53, wherein the solid phase is washed at least once using an aqueous washing liquid/washing buffer comprising a salt concentration of less than 0.2 M after binding the nucleic acid to the solid phase.

### Claim 55 (depends on 54)

The method according to claim 54, wherein the solid phase is washed at least once using an aqueous washing liquid/washing buffer comprising a salt concentration of less than 0.1 M after binding the nucleic acid to the solid phase.

### Claim 56 (depends on 55)

The method according to claim 55, wherein the solid phase is washed at least once using an aqueous washing liquid/washing buffer comprising a salt concentration of less than 50 mM after binding the nucleic acid to the solid phase.

### Claim 57 (depends on 56)

The method according to claim 56, wherein the solid phase is washed at least once using an aqueous washing liquid/washing buffer comprising a salt concentration of less than 25 mM after binding the nucleic acid to the solid phase.

### Claim 58 (depends on 16)

The method according to claim 16, wherein the solid phase is washed at least once using pure water.

### Claim 59 (depends on 16)

The method according to claim 16, wherein the solid phase is washed at least once using a washing liquid/washing buffer containing alcohol in a concentration of 5% (v/v) or lower.

### Claim 60 (depends on 59)

The method according to claim 59, wherein the solid phase is washed at least once using a washing liquid/washing buffer containing alcohol in a concentration of 3% (v/v) or lower.

### Claim 61 (depends on 60)

The method according to claim 60, wherein the solid phase is washed at least once using a washing liquid/washing buffer containing alcohol in a concentration of 1% (v/v) or lower.

### Claim 62 (depends on 61)

The method according to claim 61, wherein the solid phase is washed at least once using a washing liquid/washing buffer containing alcohol in a concentration of 0.5% or lower.

### Claim 63 (depends on 16)

The method according to claim 16, wherein the solid phase is washed at least once using a washing liquid/washing buffer that does not contain any alcohol.

### Claim 64 (depends on 16)

The method according to claim 16, wherein the solid phase is washed at least once using a washing liquid/washing buffer that does not contain ethanol or propanol.

### Claim 65 (depends on 16)

The method according to claim 16, wherein the solid phase is washed at least once using a washing liquid/washing buffer that does not contain isopropanol.

### Claim 66

A kit for isolating and/or purifying nucleic acid(s) from a sample and/or for protecting nucleic acids, comprising
(a) a binding ligand, and
(b) preferably at least one further component selected from the group consisting of:
(i) a solid phase,
(ii) a binding buffer,
(iii) an elution buffer, and
(iv) instructions for using the kit.
